Abstract
Stem cells from bone marrow, skeletal muscle and possibly other tissues can be identified by the 'side-population' (SP) phenotype. Although it has been assumed that expression of ABC transporters is responsible for this phenotype, the specific molecules involved have not been defined. Here we show that expression of the Bcrp1 (also known as Abcg2 murine/ABCG2 human) gene is a conserved feature of stem cells from a wide variety of sources. Bcrp1 mRNA was expressed at high levels in primitive murine hematopoietic stem cells, and was sharply downregulated with differentiation. Enforced expression of the ABCG2 cDNA directly conferred the SP phenotype to bone-marrow cells and caused a reduction in maturing progeny both in vitro and in transplantation-based assays. These results show that expression of the Bcrp1/ABCG2 gene is an important determinant of the SP phenotype, and that it might serve as a marker for stem cells from various sources.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Spangrude, G.J. & Johnson, G.R. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87, 7433–7437 (1990).
Wolf, N.S., Kone, A., Priestley, G.V. & Bartelmez, S.H. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342–rhodamine 123 FACS selection. Exp. Hematol. 21, 614–622 (1993).
Goodell, M.A., Brose, K., Paradis, G., Conner, A.S. & Mulligan, R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797–1806 (1996).
Goodell, M.A. et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med. 3, 1337–1345 (1997).
Jackson, K.A., Mi, T. & Goodell, M.A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA 96, 14482–14486 (1999).
Gussoni, E. et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390–394 (1999).
Hulspas, R. & Quesenberry, P.J. Characterization of neurosphere cell phenotypes by flow cytometry. Cytometry 40, 245–250 (2000).
Orkin, S.H. Stem cell alchemy. Nature Med. 6, 1212–1213 (2000).
Chaudhary, P.M. & Roninson, I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66, 85–94 (1991).
Sorrentino, B.P., McDonagh, K.T., Woods, D. & Orlic, D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 86, 491–501 (1995).
Bunting, K.D., Galipeau, J., Topham, D., Benaim, E. & Sorrentino, B.P. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92, 2269–2279 (1998).
Bunting, K.D., Zhou, S., Lu, T. & Sorrentino, B.P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 96, 902–909 (2000).
Pallis, M. & Russell, N. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. Blood 95, 2897–2904 (2000).
Johnstone, R.W., Cretney, E. & Smyth, M.J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93, 1075–1085 (1999).
Schinkel, A.H. et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94, 4028–4033 (1997).
D'Hondt, V., Caruso, M. & Bank, A. Retrovirus-mediated gene transfer of the multidrug resistance–associated protein (MRP) cDNA protects cells from chemotherapeutic agents. Hum. Gene Ther. 8, 1745–1751 (1997).
Zeng, H., Liu, G., Rea, P.A. & Kruh, G.D. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 60, 4779–4784 (2000).
Schuetz, J.D. et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nature Med. 5, 1048–1051 (1999).
Storms, R.W., Goodell, M.A., Fisher, A., Mulligan, R.C. & Smith, C. Hoechst dye efflux reveals a novel CD7+CD34− lymphoid progenitor in human umbilical cord blood. Blood 96, 2125–2133 (2000).
Osawa, M., Hanada, K., Hamada, H. & Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34− low/negative hematopoietic stem cell. Science 273, 242–245 (1996).
Nakamura, Y. et al. Ex vivo generation of CD34(+) cells from CD34(−) hematopoietic cells. Blood 94, 4053–4059 (1999).
Sato, T., Laver, J.H. & Ogawa, M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94, 2548–2554 (1999).
Klimecki, W.T., Taylor, C.W. & Dalton, W.S. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporin A analogs. J. Clin. Immunol. 15, 152–161 (1995).
Geschwind, D.H. et al. A genetic analysis of neural progenitor differentiation. Neuron 29, 325–339 (2001).
Lagasse, E. et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med. 6, 1229–1234 (2000).
Doyle, L.A. et al. A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. USA 95, 15665–15670 (1998); erratum: 96, 2569 (1999).
Miyake, K. et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res. 59, 8–13 (1999).
Maliepaard, M. et al. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 59, 4559–4563 (1999).
Good, J.R. & Kuspa, A. Evidence that a cell-type-specific efflux pump regulates cell differentiation in Dictyostelium. Dev. Biol. 220, 53–61 (2000).
Robbiani, D.R. et al. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3B, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103, 757–768 (2000).
Markowitz, D., Goff, S. & Bank, A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120–1124 (1988).
Persons, D.A., Mehaffey, M.G., Kaleko, M., Nienhuis, A.W. & Vanin, E.F. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24, 167–182 (1998).
Allay, J.A. et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med. 4, 1136–1143 (1998).
Allay, J.A. et al. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood 90, 3546–3554 (1997).
Persons, D.A. et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777–1786 (1997).
Bodine, D.M., Seidel, N.E. & Orlic, D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem-cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88, 89–97 (1996).
Acknowledgements
We thank P. Bois for providing the cDNA samples from sorted skeletal muscle SP cells; R. Ashmun for help in performing the SP assays; O. Lagutin and G. Oliver for providing specific ES cell lines for study; A. Wall for help with ABCG2 vectors; G. Kruh for his generous gift of MRP3-expressing cells; and V. D'Hondt for her gift of MRP1-expressing cells. This work was supported in part by P01 HL 53749 (to B.P.S.), R01 HL67366-01 (to B.P.S.), ASSISI Foundation of Memphis Grant 94-00 (to B.P.S.), ES05851 (to J.S.), GM60904 (to J.S.), Cancer Center Support Grant P30 CA21765, and the American Lebanese Syrian Associated Charities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, S., Schuetz, J., Bunting, K. et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7, 1028–1034 (2001). https://doi.org/10.1038/nm0901-1028
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0901-1028
This article is cited by
-
Arsenic-induced prostate cancer: an enigma
Medical Oncology (2024)
-
Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients
Stem Cell Research & Therapy (2023)
-
The net electrostatic potential and hydration of ABCG2 affect substrate transport
Nature Communications (2023)
-
The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism
Scientific Reports (2023)
-
TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma
Cellular and Molecular Life Sciences (2023)